9th Annual Biomarkers Congress

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. How to Justify Doing Less Monitoring, Sampling and Testing and Still Pass a Regulatory Inspection Tim Sandle PDA's 6th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, USA October, 2011
2. Environmental Monitoring: sterile / non-sterile Tim Sandle European Compliance Academy, 4th Microbiology Conference, Prague May, 2011
3. Developments in Regulatory Requirements Tim Sandle European Compliance Academy, 4th Microbiology Conference, Prague May, 2011
4. Approaching Sterility Testing Tim Sandle Hulst Pharma Test Expo, Cologne, Germany February, 2011
5. Cleanrooms and Air Contamination Tim Sandle VIENNI TRAINING, Prune, India, January, 2011
6. The Use of Risk Assessment in the Pharmaceutical Industry – the application if FMEA to a Sterility Testing Isolator: A Case Study Tim Sandle Pharmaceutical Microbiology Conference (SMi Group), Copthorne Tara Hotel, London January, 2011
7. Best Practices in Microbiology Training two sessions, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010 November, 2010
8. Regulatory Developments: Key Points for Microbiology Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010 November, 2010
9. Contamination control and pharmaceutical microbiology Two day course co-hosted with Dr Nigel Halls, run for Nobel Farama, Turkey, 5th & 6th January 2010 January, 2010
10. How to justify doing less monitoring, sampling and testing, and still pass a regulatory inspection Pharmig Annual Conference, Nottingham. Session run twice on 18th and 19th November 2009. November, 2009
11. Managing a Microbiology Laboratory Training Programme Co-chair, 10th June 2009, PharMIG Training Event, Dublin June, 2009
12. Best Practices in Microbiological Quality Control and Documentation co-chair / workshop presenter, 1st April 2009, Pharmig event, Cork, Republic of Ireland April, 2009
13. Best Practices in Microbiological Quality Control and Documentation co-chair / workshop presenter, 16th October 2008, Pharmig event, Northampton October, 2008
14. Managing a Microbiology Laboratory Training Programme co-chair, 27th September 2007, PharMIG Training Event, Dublin September, 2007
15. Applying Failure Mode and Effects Analysis (FMEA) to a Sterility Testing Isolator: A Case Study PharMIG Risk Based Management in Pharmaceutical Microbiology, 27th June 2007 June, 2007
16. Risk Based Management in Pharmaceutical Microbiology Chair of PharMIG Risk Based Management in Pharmaceutical Microbiology, 27th June 2007 June, 2007
17. Managing a Microbiology Laboratory Training Programme co-chair, 29th March 2007, PharMIG Training Event, Derby March, 2007
18. NHS financial crisis and the Blood Service NHS Together, Cambridge, 4th March 2007 March, 2007
19. Distribution of Microbiological Data PharMIG Irish Conference, Cork, 7th June, 2006 June, 2006
20. Hot Topics in Pharmaceutical Microbiology interactive session, PharMIG Irish Conference, Cork, Republic of Ireland, 8th June, 2006 June, 2006
21. NHS Pay Reform National Institute of Biological Standards and Control, South Mims, 18th January 2006 January, 2006
22. Hot Topics in Pharmaceutical Microbiology Two interactive sessions, PharMIG Conference, 23rd November 2005 November, 2005
23. Constructing a Viable Environmental Monitoring Programme Using a Risk Assessment Approach Pharmaceutical Cleanrooms 2005, 6th September 2005, Cambridge September, 2005
24. Environmental Monitoring Risk Assessment Institute of Validation Technology Microbiology Event of the Year’, November 2004, Amsterdam November, 2004
25. Microbiological Environmental Monitoring in an Isolator Used for Aseptic Filling or Sterility Testing AUDITS 15, Brussels, 21st September 2004 September, 2004
26. Three Aspects of LAL Testing: Glucans, Depyropgenation and Water System Qualification PharMIG Endotoxin Course, Waltham Abbey, 3rd June 2004 June, 2004
27. Practical Approaches to Sterility Test Validation PharMIG Microbiological Methods Validation Conference, Dublin, 25th March 2004 March, 2004
28. Current Practices in Sterility Testing Institute of Validation Technology Microbiology Event of the Year’, December 2003, Dublin December, 2003
29. Risk Assessment in the Pharmaceutical Industry AUDITS 13, Brussels, 16th September 2003 September, 2003
30. Sterility Testing – A Practical Approach PharMIG Microbiological Methods Validation Conference, St Albans, 4th June 2003 June, 2003
31. Monitoring: What, When and How Often? Pharmaceutical Cleanrooms, Cambridge, 18th March 2003 March, 2003
32. Future Direction of Pyrogen Testing PharMIG AGM, November 2002, Peterborough November, 2002
33. Bacterial Endotoxin Test: Introducing Methodology Parenteral Society One Day Seminar on LAL Testing, 14th March 2002, Manchester March, 2002



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
THE USE OF RISK ASSESSMENT IN THE PHARMACEUTICAL INDUSTRY - THE APPLICATION OF FMEA TO A STERILITY TESTING ISOLATOR: A CASE STUDY Pharmaceutical Microbiology January, 2011
Chairman's Opening Remarks Pharmaceutical Microbiology January, 2011

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.